Market Overview:
The Latin America generic drug market is expected to exhibit strong growth during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.
Generic drugs are bioequivalent of innovator drugs in terms of dosage, risks, strength, side effects and intended usage. These drugs can differ from their branded counterparts in size, color, shape and packaging. They are sold at lower prices as they do not require investments in clinical studies to demonstrate the effectiveness of the medicine. Consequently, the demand for generic drugs is rising in the Latin American region.
The significant pediatric population, along with the increasing number of individuals who have Alzheimer’s disease, osteoarthritis, and rheumatoid arthritis, represents one of the key factors propelling the growth of the generic drug market in the Latin American region. Moreover, governing authorities in the region are investing in the healthcare sector, which is contributing to the market growth. Other factors, such as the burgeoning pharmaceutical industry and inflating income levels of individuals, are driving the market further. However, the recent outbreak of the coronavirus disease (COVID-19) pandemic and the imposition of lockdown restrictions have halted the production of generic drugs, which has impacted the market. The market will recover once lockdown relaxations are introduced.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the Latin America generic drug market report, along with forecasts for growth at the regional and country level from 2021-2026. Our report has categorized the market based on segment, therapy area, drug delivery and distribution channel.
Breakup by Segment:
- Unbranded Generics
- Branded Generics
Breakup by Therapy Area:
- Central Nervous System
- Cardiovascular
- Dermatology
- Genitourinary/Hormonal
- Respiratory
- Rheumatology
- Diabetes
- Oncology
- Others
Breakup by Drug Delivery:
- Oral
- Injectables
- Dermal/Topical
- Inhalers
Breakup by Distribution Channel:
- Retail Pharmacies
- Hospital Pharmacies
Breakup by Country:
- Brazil
- Mexico
- Argentina
- Columbia
- Chile
- Peru
- Others
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players.
Report Coverage:
| Report Features |
Details |
|---|
| Base Year of the Analysis |
2020 |
| Historical Period |
2015-2020 |
| Forecast Period |
2021-2026 |
| Units |
US$ Million |
| Segment Coverage |
Segment, Therapy Area, Drug Delivery, Distribution Channel, Country |
| Countries Covered |
Brazil, Mexico, Argentina, Columbia, Chile, Peru, Others |
| Customization Scope |
10% Free Customization |
| Report Price and Purchase Option |
Single User License $ 2499
Five User License $ 2999
Corporate License $ 3999 |
| Post-Sale Analyst Support |
10-12 Weeks |
| Delivery Format |
PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
Key Questions Answered in This Report:
- How has the Latin America generic drug market performed so far and how will it perform in the coming years?
- What has been the impact of COVID-19 on the Latin America generic drug market?
- What are the key regional markets?
- What is the breakup of the market based on the segment?
- What is the breakup of the market based on the therapy area?
- What is the breakup of the market based on the drug delivery?
- What is the breakup of the market based on the distribution channel?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the Latin America generic drug market and who are the key players?
- What is the degree of competition in the industry?
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Latin America Generic Drug Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Segment
6.1 Unbranded Generics
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Branded Generics
6.2.1 Market Trends
6.2.2 Market Forecast
7 Market Breakup by Therapy Area
7.1 Central Nervous System
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Cardiovascular
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Dermatology
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Genitourinary/Hormonal
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Respiratory
7.5.1 Market Trends
7.5.2 Market Forecast
7.6 Rheumatology
7.6.1 Market Trends
7.6.2 Market Forecast
7.7 Diabetes
7.7.1 Market Trends
7.7.2 Market Forecast
7.8 Oncology
7.8.1 Market Trends
7.8.2 Market Forecast
7.9 Others
7.9.1 Market Trends
7.9.2 Market Forecast
8 Market Breakup by Drug Delivery
8.1 Oral
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Injectables
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Dermal/Topical
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Inhalers
8.4.1 Market Trends
8.4.2 Market Forecast
9 Market Breakup by Distribution Channel
9.1 Retail Pharmacies
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Hospital Pharmacies
9.2.1 Market Trends
9.2.2 Market Forecast
10 Market Breakup by Country
10.1 Brazil
10.1.1 Market Trends
10.1.2 Market Breakup by Segment
10.1.3 Market Breakup by Therapy Area
10.1.4 Market Breakup by Drug Delivery
10.1.5 Market Breakup by Distribution Channel
10.1.6 Market Forecast
10.2 Mexico
10.2.1 Market Trends
10.2.2 Market Breakup by Segment
10.2.3 Market Breakup by Therapy Area
10.2.4 Market Breakup by Drug Delivery
10.2.5 Market Breakup by Distribution Channel
10.2.6 Market Forecast
10.3 Argentina
10.3.1 Market Trends
10.3.2 Market Breakup by Segment
10.3.3 Market Breakup by Therapy Area
10.3.4 Market Breakup by Drug Delivery
10.3.5 Market Breakup by Distribution Channel
10.3.6 Market Forecast
10.4 Colombia
10.4.1 Market Trends
10.4.2 Market Breakup by Segment
10.4.3 Market Breakup by Therapy Area
10.4.4 Market Breakup by Drug Delivery
10.4.5 Market Breakup by Distribution Channel
10.4.6 Market Forecast
10.5 Chile
10.5.1 Market Trends
10.5.2 Market Breakup by Segment
10.5.3 Market Breakup by Therapy Area
10.5.4 Market Breakup by Drug Delivery
10.5.5 Market Breakup by Distribution Channel
10.5.6 Market Forecast
10.6 Peru
10.6.1 Market Trends
10.6.2 Market Breakup by Segment
10.6.3 Market Breakup by Therapy Area
10.6.4 Market Breakup by Drug Delivery
10.6.5 Market Breakup by Distribution Channel
10.6.6 Market Forecast
10.7 Others
10.7.1 Market Trends
10.7.2 Market Breakup by Segment
10.7.3 Market Breakup by Therapy Area
10.7.4 Market Breakup by Drug Delivery
10.7.5 Market Breakup by Distribution Channel
10.7.6 Market Forecast
11 SWOT Analysis
11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats
12 Value Chain Analysis
13 Porters Five Forces Analysis
13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes
14 Price Analysis
15 Policy and Regulatory Landscape
16 Competitive Landscape
16.1 Market Structure
16.2 Key Players
16.3 Profiles of Key Players
List of Figures
Figure 1: Latin America: Generic Drug Market: Major Drivers and Challenges
Figure 2: Latin America: Generic Drug Market: Sales Value (in Million US$), 2015-2020
Figure 3: Latin America: Generic Drug Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 4: Latin America: Generic Drug Market: Breakup by Segment (in %), 2020
Figure 5: Latin America: Generic Drug Market: Breakup by Therapy Area (in %), 2020
Figure 6: Latin America: Generic Drug Market: Breakup by Drug Delivery (in %), 2020
Figure 7: Latin America: Generic Drug Market: Breakup by Distribution Channel (in %), 2020
Figure 8: Latin America: Generic Drug Market: Breakup by Country (in %), 2020
Figure 9: Latin America: Generic Drug (Unbranded Generics) Market: Sales Value (in Million US$), 2015 & 2020
Figure 10: Latin America: Generic Drug (Unbranded Generics) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 11: Latin America: Generic Drug (Branded Generics) Market: Sales Value (in Million US$), 2015 & 2020
Figure 12: Latin America: Generic Drug (Branded Generics) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 13: Latin America: Generic Drug (Central Nervous System) Market: Sales Value (in Million US$), 2015 & 2020
Figure 14: Latin America: Generic Drug (Central Nervous System) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 15: Latin America: Generic Drug (Cardiovascular) Market: Sales Value (in Million US$), 2015 & 2020
Figure 16: Latin America: Generic Drug (Cardiovascular) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 17: Latin America: Generic Drug (Dermatology) Market: Sales Value (in Million US$), 2015 & 2020
Figure 18: Latin America: Generic Drug (Dermatology) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 19: Latin America: Generic Drug (Genitourinary/Hormonal) Market: Sales Value (in Million US$), 2015 & 2020
Figure 20: Latin America: Generic Drug (Genitourinary/Hormonal) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 21: Latin America: Generic Drug (Respiratory) Market: Sales Value (in Million US$), 2015 & 2020
Figure 22: Latin America: Generic Drug (Respiratory) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 23: Latin America: Generic Drug (Rheumatology) Market: Sales Value (in Million US$), 2015 & 2020
Figure 24: Latin America: Generic Drug (Rheumatology) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 25: Latin America: Generic Drug (Diabetes) Market: Sales Value (in Million US$), 2015 & 2020
Figure 26: Latin America: Generic Drug (Diabetes) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 27: Latin America: Generic Drug (Oncology) Market: Sales Value (in Million US$), 2015 & 2020
Figure 28: Latin America: Generic Drug (Oncology) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 29: Latin America: Generic Drug (Other Therapy Areas) Market: Sales Value (in Million US$), 2015 & 2020
Figure 30: Latin America: Generic Drug (Other Therapy Areas) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 31: Latin America: Generic Drug (Oral) Market: Sales Value (in Million US$), 2015 & 2020
Figure 32: Latin America: Generic Drug (Oral) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 33: Latin America: Generic Drug (Injectables) Market: Sales Value (in Million US$), 2015 & 2020
Figure 34: Latin America: Generic Drug (Injectables) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 35: Latin America: Generic Drug (Dermal/Topical) Market: Sales Value (in Million US$), 2015 & 2020
Figure 36: Latin America: Generic Drug (Dermal/Topical) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 37: Latin America: Generic Drug (Inhalers) Market: Sales Value (in Million US$), 2015 & 2020
Figure 38: Latin America: Generic Drug (Inhalers) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 39: Latin America: Generic Drug (Retail Pharmacies) Market: Sales Value (in Million US$), 2015 & 2020
Figure 40: Latin America: Generic Drug (Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 41: Latin America: Generic Drug (Hospital Pharmacies) Market: Sales Value (in Million US$), 2015 & 2020
Figure 42: Latin America: Generic Drug (Hospital Pharmacies) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 43: Brazil: Generic Drug Market: Sales Value (in Million US$), 2015 & 2020
Figure 44: Brazil: Generic Drug Market: Breakup by Segment (in %), 2020
Figure 45: Brazil: Generic Drug Market: Breakup by Therapy Area (in %), 2020
Figure 46: Brazil: Generic Drug Market: Breakup by Drug Delivery (in %), 2020
Figure 47: Brazil: Generic Drug Market: Breakup by Distribution Channel (in %), 2020
Figure 48: Brazil: Generic Drug Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 49: Mexico: Generic Drug Market: Sales Value (in Million US$), 2015 & 2020
Figure 50: Mexico: Generic Drug Market: Breakup by Segment (in %), 2020
Figure 51: Mexico: Generic Drug Market: Breakup by Therapy Area (in %), 2020
Figure 52: Mexico: Generic Drug Market: Breakup by Drug Delivery (in %), 2020
Figure 53: Mexico: Generic Drug Market: Breakup by Distribution Channel (in %), 2020
Figure 54: Mexico: Generic Drug Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 55: Argentina: Generic Drug Market: Sales Value (in Million US$), 2015 & 2020
Figure 56: Argentina: Generic Drug Market: Breakup by Segment (in %), 2020
Figure 57: Argentina: Generic Drug Market: Breakup by Therapy Area (in %), 2020
Figure 58: Argentina: Generic Drug Market: Breakup by Drug Delivery (in %), 2020
Figure 59: Argentina: Generic Drug Market: Breakup by Distribution Channel (in %), 2020
Figure 60: Argentina: Generic Drug Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 61: Colombia: Generic Drug Market: Sales Value (in Million US$), 2015 & 2020
Figure 62: Colombia: Generic Drug Market: Breakup by Segment (in %), 2020
Figure 63: Colombia: Generic Drug Market: Breakup by Therapy Area (in %), 2020
Figure 64: Colombia: Generic Drug Market: Breakup by Drug Delivery (in %), 2020
Figure 65: Colombia: Generic Drug Market: Breakup by Distribution Channel (in %), 2020
Figure 66: Colombia: Generic Drug Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 67: Chile: Generic Drug Market: Sales Value (in Million US$), 2015 & 2020
Figure 68: Chile: Generic Drug Market: Breakup by Segment (in %), 2020
Figure 69: Chile: Generic Drug Market: Breakup by Therapy Area (in %), 2020
Figure 70: Chile: Generic Drug Market: Breakup by Drug Delivery (in %), 2020
Figure 71: Chile: Generic Drug Market: Breakup by Distribution Channel (in %), 2020
Figure 72: Chile: Generic Drug Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 73: Peru: Generic Drug Market: Sales Value (in Million US$), 2015 & 2020
Figure 74: Peru: Generic Drug Market: Breakup by Segment (in %), 2020
Figure 75: Peru: Generic Drug Market: Breakup by Therapy Area (in %), 2020
Figure 76: Peru: Generic Drug Market: Breakup by Drug Delivery (in %), 2020
Figure 77: Peru: Generic Drug Market: Breakup by Distribution Channel (in %), 2020
Figure 78: Peru: Generic Drug Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 79: Others: Generic Drug Market: Sales Value (in Million US$), 2015 & 2020
Figure 80: Others: Generic Drug Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 81: Latin America: Generic Drug Industry: SWOT Analysis
Figure 82: Latin America: Generic Drug Industry: Value Chain Analysis
Figure 83: Latin America: Generic Drug Industry: Porter’s Five Forces Analysis
List of Tables
Table 1: Latin America: Generic Drug Market: Key Industry Highlights, 2020 and 2026
Table 2: Latin America: Generic Drug Market Forecast: Breakup by Segment (in Million US$), 2020-2025
Table 3: Latin America: Generic Drug Market Forecast: Breakup by Therapy Area (in Million US$), 2020-2025
Table 4: Latin America: Generic Drug Market Forecast: Breakup by Drug Delivery (in Million US$), 2020-2025
Table 5: Latin America: Generic Drug Market Forecast: Breakup by Distribution Channel (in Million US$), 2020-2025
Table 6: Latin America: Generic Drug Market Forecast: Breakup by Country (in Million US$), 2020-2025
Table 7: Latin America: Generic Drug Market: Competitive Structure
Table 8: Latin America: Generic Drug Market: Key Players